Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma
Clinical trial NCT04154943 · COMPLETED
Trial details
- NCT number
- NCT04154943
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2021-12-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.